Skip to content
Media

The Rise of High-Tech, Needle-Free Facials: EMFACE® Surpasses One Million Treatments Globally

BTL Aesthetics Australia 2 mins read

The Rise of High-Tech, Needle-Free Facials: EMFACE® Surpasses One Million Treatments Globally

In an age where “natural results” and minimal downtime are top of mind, the beauty industry continues to innovate with non-invasive devices that aim to support facial structure and skin appearance—without the use of needles or surgery.

One such treatment leading this shift is EMFACE®, a device that has now been used in over one million treatments worldwide. Tapping into the growing demand for advanced skin and facial care, EMFACE is available in select clinics across Australia under the guidance of qualified healthcare professionals.

What Is EMFACE®?

EMFACE is a TGA-registered medical device (ARTG Identifiers 393998 and 394105) that combines High-Intensity Facial Electrical Stimulation (HIFES™) and Synchronized Radiofrequency (RF) in a single session. These technologies are intended to support:

  • Local muscle stimulation

  • Local tissue heating

  • Increased local blood circulation

  • Strengthening of facial muscles

  • Supporting the reduction of facial wrinkles and rhytids

Treatments are typically completed in approximately 20 minutes and involve no needles or surgical intervention. Individual experiences vary and treatment suitability must be assessed by a qualified practitioner.

A Focus on Natural-Looking Results

As the trend toward “tech facials” continues to grow, EMFACE reflects a broader industry move toward non-invasive, device-led treatments that focus on subtle yet noticeable results. With no injectables or downtime, the technology may appeal to those exploring preventative or maintenance-based aesthetic options under professional care.

The device’s new Eye Applicators—also included in its TGA registration—have been developed to support facial muscle stimulation around the eye area, giving practitioners additional tools to tailor treatments for individual facial regions.

Available at Leading Clinics

EMFACE is currently offered by a number of authorised Australian clinics, where treatments are customised by healthcare professionals based on individual needs and clinical judgement.

To learn more about EMFACE or find an authorised clinic:
🔗 btlaesthetics.com.au/for-providers/emface-providers


Media Enquiries
Simone Wyndham | Beauty PR Sydney
📧 [email protected]

Healthcare Professional Enquiries
Gareth Pepper | BTL Aesthetics Australia
📧 [email protected] | 📞 +61 (0) 435 769 639


Important Information:
• Always read the label and follow the directions for use.
• This product is not available for purchase by the general public and is intended for use by qualified healthcare professionals only.
• Consult a healthcare professional to determine if this treatment is appropriate for your needs.
• Patient experience and results may vary.


About us:

Founded in 1993, BTL Aesthetics is a leading innovator in non-invasive medical and aesthetic devices, with products including EMSCULPT NEO®, EXION™, EMSELLA®, and EXILIS ULTRA 360®. Operating in over 80 countries, BTL is committed to developing evidence-based technologies to support body contouring, facial rejuvenation, and intimate health.
🌐 Learn more: btlaesthetics.com.au

Media

More from this category

  • Marketing Advertising, Media
  • 11/12/2025
  • 17:19
Medianet

Low prices, not share prices: New study reveals the media’s impact on consumer trust

Key Facts: A new report from Medianet oncovers key drives of positive sentiment and strong brand reputation on some of Australia’s most trusted brands.…

  • Contains:
  • Media
  • 11/12/2025
  • 00:55
dentsu

The Native Brand, P&G Studios and dentsu Entertainment Launch America’s First Brand Co-Produced Feature-Length “Microsoap” for the Vertical Video Era Produced by Pixie USA, Titled “The Golden Pear Affair”

Trailer and series launch in January 2026; social-first distribution to be followed with a proprietary app experienceLOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Native, a clean beauty and personal care brand, P&G Studios, a division of Procter & Gamble, and dentsu Entertainment, a division of dentsu, today announced the first brand co-produced feature-length “microsoap” in the US. The social-first, short-form scripted series, “The Golden Pear Affair,” produced by Pixie USA, reimagines the classic soap opera for the vertical, mobile-first era. Designed for today’s swipe savvy audiences, the new “microsoap” format delivers fast-paced storytelling with cliff-hangers and character arcs in…

  • Media, Women
  • 10/12/2025
  • 22:12
Faceproof Pty Ltd

With the dangers that come with online dating, gaming, and digital business, Faceproof takes the fear out of every interaction.

Key Facts: https://share.synthesia.io/04917377-3526-4699-8614-ab65bef89acb FOR IMMEDIATE RELEASEDate: 10 December 2025 www.faceproof.ai — https://share.synthesia.io/04917377-3526-4699-8614-ab65bef89acb Brisbane, AU – Today marks the official launch of www.faceproof.ai, a powerful…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.